Исследование терапевтической эффективности ксимедона при диабетической полиневропатии

Кадырова Лидия Ринадовна, Alexander Rogozhin, Р. Х. Хафизьянова · Pacific Medical Journal · 2014

Background. Social and economic loss because of diabetic polyneuropathy are extremely high and this factor determines the importance of the research for the new pharmacological agents for diabetic polyneuropathy correction. Methods. Been provided prospective, randomized, controlled clinical trial of the “Xymedone” efficacy as the part of the baseline therapy for polyneuropathy in more than 97 patients with diabetes mellitus. Results. The significant reduction of diabetic polyneuropathy symptoms severity in patients been taking Xymedone, in comparing with the effect of baseline therapy. Conclusions. Xymedone normalizes the nerve conduction velocity, increases the pain threshold and corrects vibration sensitivity in patients with diabetes mellitus.

Cited by 0 works.

Authors